NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE216037 Query DataSets for GSE216037
Status Public on Oct 24, 2022
Title TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: a multi-omics study 1 microenvironment characteristic
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (BLCA), which is implicated in the pathogenesis of tumor. However, the cellular mechanisms of TP53 mutations are complicated, yet well-defined, but their clinical prognostic value in the management of BLCA remains controversial. This study aimed to explore the role of TP53 mutation in regulating the tumor microenvironment (TME), elucidate the effects of TP53 activity on BLCA prognosis and immunotherapy response. Methods: A TP53-related signature based on TP53-induced and TP53-repressed genes was used to construct a TP53 activity-related score and classifier. The abundance of different immune cell types was determined using CIBERSORT to estimate immune cell infiltration. Moreover, the heterogeneity of the tumor immune microenvironment between the high and low TP53 score groups was further evaluated using single-cell mass cytometry (CyTOF) and imaging mass cytometry (IMC). Moreover, pathway enrichment analysis was performed to explore the differential biological functions between tumor epithelial cells with high and low TP53 activity scores. Finally, the receptor–ligand interactions between immune cells and tumor epithelial cells harboring distinct TP53 activity were analyzed by single-cell RNA-sequencing. Results: The TP53 activity-related gene signature differentiated well between TP53 functional retention and inactivation in BLCA. BLCA patients with low TP53 scores had worse survival prognosis, more TP53 mutations, higher grade, and stronger lymph node metastasis than those with high TP53 scores. Additionally, CyTOF and IMC analyses revealed that BLCA patients with low TP53 scores exhibited a potent immunosuppressive TME. Consistently, single-cell sequencing results showed that tumor epithelial cells with low TP53 scores were significantly associated with high cell proliferation and stemness abilities and strongly interacted with immunosuppressive receptor–ligand pairs. Conclusions: Patients with BLCA with low TP53 scores have a worse prognosis and a more immunosuppressive TME. This TP53 activity-related signature can serve as a potential prognostic signature for predicting the immune response, which may facilitate the development of new strategies for immunotherapy in BLCA. Keywords: bladder cancer, TP53, immunosuppression, tumor microenvironment
 
Overall design RNA-seq of bladder cancer
 
Contributor(s) Tao Y, Li X, Zhang Y, Wang Q, Wang X
Citation(s) 36568387
Submission date Oct 18, 2022
Last update date Jan 06, 2023
Contact name Zhenxing Wang
E-mail(s) wangxi@stu.gxmu.edu.cn
Phone 15878767078
Organization name Guangxi Medicla University
Department Center for Genomic and Personalized Medicine
Street address Zhongshan Street
City Nanning
State/province Guangxi
ZIP/Postal code 530021
Country China
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (52)
GSM6656519 BC1
GSM6656520 BC2
GSM6656521 BC3
Relations
BioProject PRJNA891747

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE216037_GEO-pdata_.csv.gz 1.1 Kb (ftp)(http) CSV
GSE216037_Processed_data.csv.gz 4.7 Mb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap